 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2006, vol. 12, issue 1
Subject Collection: Medicine
Page: 7-10
DOI: 10.5272/jimab.2006121.7
Online date: November 4, 2006
J of IMAB 2006; 12(1):7-10
MYCOPHENOLATE MOFETIL IN TREATMENT OF CHRONIC GLOMERULONEPHRITIS.
Liliya O. Zub
UInstitute of Nephrology, Kyiv, Ukraine
ABSTRACT:
This article studies the action of mycophenolate mofetil (Cell-Cept) on the rates of cell immunity, the level of proteinuria. There was also determined its safe usage in patients with chronic glomerulonephritis concomitant by nephrotic syndrome and the preserved renal function. Cell-Cept was proved to be successfully used in the immunosuppressive therapy of patients with membranous glomerulonephritis, as it is easily endured by patients and it has no considerable side effects. No valuable positive alterations were found in patients with focal segmental glomerulosclerosis after Cell-Cept administration during 6 months.
Key words: mycophenolate mofetil, Cell-Cept.
- Download FULL TEXT (PDF - 578 KB)
Please cite this article as:
Zub LO. MYCOPHENOLATE MOFETIL IN TREATMENT OF CHRONIC GLOMERULONEPHRITIS. J of IMAB. 2006; 12(1):7-10; DOI:10.5272/jimab.2006121.7
REFERENCES:
1. Николаенко А.Н. Международная заявка РСТ/UА93/0003 "Биологически активное средство, способ его получения, препарат, содержавший указанное средство и способ использования препарата". 1993. [in Russian]
2. Битти В., Моррисон Р., Персистенция хламидий: от клеточных культур до патогенеза хламидийной инфекции. Заболевания передающиеся половым путем. - 1995. No. 6. C.3-24. [in Russian]
3. Малышев И.Ю. Введение в биохимию оксида азота. Роль оксида азота в регуляции основных систем организма. Рос. журнал гастроэнтерологии, гепатологии, колопроктологии. -1997.-No.1. С. 49-55. [in Russian]
4. Janeway CA, et al. Immunobiology: The Immune System in Health and Disease. New York, NY: Current Biology Publications; London, England: Elsevier Science London/Garland Publishing, 1999.
5. Dinarello CA. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51-95. [PubMed]
6. Blesson S, Thiery J, Gaudin C, Stancou R, Kolb JP, Moreau JL, et al. Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. Int Immunol. 2002 Oct;14(10):1169-78.Rev Infect Dis. 1984 Jan-Feb;6(1):51-95. [PubMed] [CrossRef]
7. Igietseme JU, Uriri IM, Chow M, Abe E, Rank RG. Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem Biophys Res Commun. 1997 Mar 27;232(3):595-601. [PubMed] [CrossRef]